EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSBTAG00000004688
Gene Symbol: DHCR24
6 Enzyme and pathways 5 Cross references
220 Possible Orthologues:

26s Proteasome Complex Subunit Sem1

Ensembl ID : ENSBTAG00000034496
Gene Symbol: LOC101907965
4 Cross references
158 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSBTAG00000007840
Gene Symbol: HMGCR
4 Enzyme and pathways 5 Cross references
284 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSBTAG00000034436
Gene Symbol: PDPK1
39 Enzyme and pathways 5 Cross references
256 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase

Ensembl ID : ENSBTAG00000004175
Gene Symbol: HPD
4 Enzyme and pathways 5 Cross references
219 Possible Orthologues:

40s Ribosomal Protein S12

Ensembl ID : ENSBTAG00000019007
Gene Symbol: LOC511302
4 Cross references
149 Possible Orthologues:

40s Ribosomal Protein S13-Like

Ensembl ID : ENSBTAG00000003937
Gene Symbol: LOC504858
4 Cross references
295 Possible Orthologues:

5'-Nucleotidase Ecto

Ensembl ID : ENSBTAG00000048655
Gene Symbol: NT5E
8 Enzyme and pathways 4 Cross references
262 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 3, Family Member C-Like

Ensembl ID : ENSBTAG00000039011
Gene Symbol: LOC532114
3 Enzyme and pathways 4 Cross references
84 Possible Orthologues:

5-Hydroxytryptamine Receptor 1b

Ensembl ID : ENSBTAG00000037429
Gene Symbol: HTR1B
8 Enzyme and pathways 5 Cross references
256 Possible Orthologues:

5-Hydroxytryptamine Receptor 1e

Ensembl ID : ENSBTAG00000026580
Gene Symbol: HTR1E
8 Enzyme and pathways 5 Cross references
169 Possible Orthologues:

5-Hydroxytryptamine Receptor 1f

Ensembl ID : ENSBTAG00000039151
Gene Symbol: HTR1F
8 Enzyme and pathways 5 Cross references
157 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).